The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Unveiling the Structure-Activity Relationships at the Orthosteric Binding Site of P2X Ion Channels: The Route to Selectivity.EBI
European Institute For Molecular Imaging (Eimi)
Discovery of 5-methyl-1H-benzo[d]imidazole derivatives as novel P2X3 Receptor antagonists.EBI
Gwangju Institute of Science and Technology (Gist)
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Dioxotriazine derivatives as a new class of P2XEBI
Shionogi
New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds.EBI
Gedeon Richter
Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.EBI
Hoffmann-La Roche
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screening.EBI
Shionogi
6-azaindole compoundsBDB
Bristol-Myers Squibb
Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.BDB
Panjab University
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.BDB
Wichita State University